Platelet Rich Plasma Therapy Prp Market
PUBLISHED: 2023 ID: SMRC24332
SHARE
SHARE

Platelet Rich Plasma Therapy Prp Market

Platelet-rich Plasma Therapy (prp) Market Forecasts to 2030 - Global Analysis By Type (Pure-Platelet-rich Plasma (P-PRP), Leukocyte-rich Platelet-rich Plasma (L-PRP), Pure-Platelet-rich Fibrin (P-PRF), Leukocyte-rich Platelet-rich Fibrin (L-PRF), Activated PRP, Autologous Conditioned Plasma (ACP), Cellular PRP and Other Types), Source (Autologous, Allogenic and Other Sources), Application, End User and by Geography

4.4 (21 reviews)
4.4 (21 reviews)
Published: 2023 ID: SMRC24332

This report covers the impact of COVID-19 on this global market
Loading...

Years Covered

2021-2030

Estimated Year Value (2023)

US $710.94 MN

Projected Year Value (2030)

US $1887.65 MN

CAGR (2023 - 2030)

14.97%

Regions Covered

North America, Europe, Asia Pacific, South America, and Middle East & Africa

Countries Covered

US, Canada, Mexico, Germany, UK, Italy, France, Spain, Japan, China, India, Australia, New Zealand, South Korea, Rest of Asia Pacific, South America, Argentina, Brazil, Chile, Middle East & Africa, Saudi Arabia, UAE, Qatar, and South Africa

Largest Market

North America

Highest Growing Market

Asia Pacific


According to Stratistics MRC, the Global Platelet-rich Plasma Therapy (PRP) Market is accounted for $710.94 million in 2023 and is expected to reach $1,887.65 million by 2030 growing at a CAGR of 14.97% during the forecast period. A state-of-the-art medical technique called platelet-rich plasma therapy (PRP) uses the body's own natural healing abilities to encourage tissue regeneration. In order to concentrate the platelets—which are abundant in growth factors and proteins necessary for tissue repair—a small amount of the patient's blood is extracted during the course of the treatment. 

According to the American Red Cross, PRP is greater than or equal to 5.5 × 1010 platelets per 50 mL. This translates to a two- to sevenfold increase in platelet concentration compared with that of whole blood. The normal human range of platelet concentration is 150 000 to 450 000 platelets per µL of whole venous blood.

Market Dynamics: 

Driver: 

Growing need for non-surgical and low-invasive therapies

Patients' increasing preference for procedures with less downtime and a lower risk of complications is driving the demand for non-surgical and minimally invasive treatments. PRP therapy is in line with this trend by providing a less invasive treatment for ailments like skin rejuvenation, tendon injuries, and chronic joint pain. Additionally, the concept of utilizing the body's natural healing processes instead of requiring extensive surgery appeals to patients.

Restraint:

Strict insurance protection

The limited insurance provider coverage of PRP therapy is a major impediment. PRP treatment is frequently paid for by the patient, which may be a deterrent for some people interested in this regenerative medicine. Moreover, a lack of broad insurance support could make it more difficult to use and less affordable, which would restrict its adoption, especially in areas where people rely more heavily on insurance.

Opportunity:

Increasing the use of clinical applications

An interesting prospect is the continuous investigation of novel clinical uses for PRP therapy. Determining PRP's regenerative potential in diseases that haven't been studied before can be the focus of future research. Additionally, PRP's potential therapeutic utility may be expanded by further investigating its effectiveness in neurology, cardiovascular medicine, and autoimmune disorders, among other diseases.

Threat:

Insufficient scientific consensus

The legitimacy of the therapy is at risk since there is no accepted definition or set of procedures for the preparation and administration of PRP. Moreover, healthcare providers may become skeptical of one another if treatment parameters and processing techniques vary and produce inconsistent results. To counter this threat, a unified scientific consensus must be established through research and consensus-building efforts.

Covid-19 Impact: 

The market for platelet-rich plasma (PRP) therapy has been impacted by the COVID-19 pandemic in a number of ways. On the one hand, the adoption of PRP therapy has been impacted by the temporary slowdown in elective and non-urgent medical procedures brought on by disruptions in healthcare services, lockdowns, and resource reallocation towards pandemic response. However, the pandemic has highlighted the significance of regenerative medicine, placing a greater focus on patient-centered care and minimally invasive procedures. As healthcare systems stabilize, there should be a rise in demand for PRP therapy in the post-COVID recovery period, particularly in musculoskeletal conditions and aesthetic applications.

The Leukocyte-rich Platelet-rich Plasma (L-PRP) segment is expected to be the largest during the forecast period

The segment leukocyte-rich platelet-rich plasma (L-PRP) holds the largest share. A higher concentration of white blood cells, which are thought to be involved in tissue regeneration and the immune response, is a characteristic of L-PRP. This particular segment is preferred in some medical applications, especially in orthopedics, where the anti-inflammatory characteristics of leukocytes may help treat ailments like tendon injuries and osteoarthritis. Moreover, leukocytes are assumed to augment PRP's overall regenerative capacity, rendering L-PRP favored option in particular clinical situations. L-PRP has also been used in oral and maxillofacial surgery.

The Aesthetic Medicine segment is expected to have the highest CAGR during the forecast period

In the platelet-rich plasma (PRP) market, the aesthetic medicine segment is projected to have the highest CAGR. PRP therapy use in aesthetic medicine has increased dramatically, especially in cosmetic dermatology and facial rejuvenation. PRP is a sought-after treatment for skin rejuvenation, wrinkle reduction, and hair restoration because of its regenerative qualities, which encourage collagen production and tissue repair. Additionally, PRP treatments are minimally invasive, which is in line with the rising popularity of non-surgical aesthetic procedures. PRP is becoming more and more popular among people looking for long-lasting, natural cosmetic solutions as a result of growing knowledge of its efficacy in improving skin texture, treating hair loss, and improving overall facial aesthetics.

Region with largest share:

With the largest market share for platelet-rich plasma (PRP), North America has been a dominant region in the industry. Due to a number of factors, including a highly prevalent patient population that can benefit from regenerative therapies, substantial investment in research and development, and an advanced healthcare infrastructure, the United States in particular has contributed significantly to the growth of the PRP market. Furthermore, PRP treatments are now widely used in many medical specialties, including orthopedics, dermatology, and sports medicine. This is due in part to the region's strong focus on technological innovation in healthcare and its well-established regulatory framework.

Region with highest CAGR:

In terms of platelet-rich plasma (PRP) market growth, the Asia-Pacific region is projected to have the highest CAGR. As the world's population ages and becomes more aware of cutting-edge medical treatments, as well as the increasing prevalence of orthopedic and cosmetic concerns, the Asia-Pacific region—which includes countries like China, Japan, India, and South Korea—is seeing a sharp increase in demand for regenerative medicine. Plus, PRP therapy is becoming more and more popular in the areas of musculoskeletal disorders and sports medicine. Moreover, the area's growing importance in the global PRP market is a result of government initiatives supporting the development of healthcare infrastructure as well as a growing focus on medical tourism.

Key players in the market

Some of the key players in Platelet-rich Plasma Therapy (PRP) market include Arthrex, Inc, Zimmer Biomet, EmCyte Corporation, Dr. PRP USA LLC, Juventix Regenerative Medical LLC, Johnson & Johnson Services, Inc., Terumo Corporation, Stryker, Apex Biologix and Celling Biosciences, Inc.

Key Developments:

In June 2023, Dr. PRP USA LLC is proud to announce it has received 510K approval from the Food & Drug Administration (FDA) for its PRP kits. Now that the 510K clearance is final, Dr. PRP can continue to expand its market providing PRP kits to medical providers.

In May 2023, Zimmer Biomet Holdings, Inc., a global medical technology leader, announced it has reached a definitive agreement to acquire OSSIS, a privately-held medical device company that specializes in personalized 3D printed implants, as well as complex hip replacements, including second-time hip replacements and replacements involving bone tumors and trauma. 

In January 2023, Arthrex, a global leader in minimally invasive surgical technology, announced its ACL TightRope implant has received clearance from the U.S. Food and Drug Administration (FDA) for pediatric indications. The TightRope implant is used in the surgical treatment of orthopedic injuries and is the first and only fixation device for anterior cruciate ligament (ACL) injuries cleared for pediatric use.

Types Covered:
• Pure-Platelet-rich Plasma (P-PRP)
• Leukocyte-rich Platelet-rich Plasma (L-PRP)
• Pure-Platelet-rich Fibrin (P-PRF)
• Leukocyte-rich Platelet-rich Fibrin (L-PRF)
• Activated PRP
• Autologous Conditioned Plasma (ACP)
• Cellular PRP
• Other Types 
 
Sources Covered:
• Autologous
• Allogenic
• Other Sources

Applications Covered:
• Orthopedics
• Dermatology
• Dental
• Sports Medicine
• Chronic Wounds
• Ophthalmology
• Aesthetic Medicine
• Cardiac Muscle Injury
• Other Applications 

End Users Covered:
• Hospitals
• Clinics
• Research and Academic Institutes
• Other End Users 

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan        
o China        
o India        
o Australia  
o New Zealand
o South Korea
o Rest of Asia Pacific    
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa 
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Free Customization Offerings: 
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary             
              
2 Preface             
 2.1 Abstract            
 2.2 Stake Holders            
 2.3 Research Scope            
 2.4 Research Methodology            
  2.4.1 Data Mining           
  2.4.2 Data Analysis           
  2.4.3 Data Validation           
  2.4.4 Research Approach           
 2.5 Research Sources            
  2.5.1 Primary Research Sources           
  2.5.2 Secondary Research Sources           
  2.5.3 Assumptions           
              
3 Market Trend Analysis             
 3.1 Introduction            
 3.2 Drivers            
 3.3 Restraints            
 3.4 Opportunities            
 3.5 Threats            
 3.6 Application Analysis            
 3.7 End User Analysis            
 3.8 Emerging Markets            
 3.9 Impact of Covid-19            
              
4 Porters Five Force Analysis             
 4.1 Bargaining power of suppliers            
 4.2 Bargaining power of buyers            
 4.3 Threat of substitutes            
 4.4 Threat of new entrants            
 4.5 Competitive rivalry            
            ,   
5 Global Platelet-rich Plasma Therapy (prp) Market, By Type             
 5.1 Introduction            
 5.2 Pure-Platelet-rich Plasma (P-PRP)            
 5.3 Leukocyte-rich Platelet-rich Plasma (L-PRP)            
 5.4 Pure-Platelet-rich Fibrin (P-PRF)            
 5.5 Leukocyte-rich Platelet-rich Fibrin (L-PRF)            
 5.6 Activated PRP            
 5.7 Autologous Conditioned Plasma (ACP)            
 5.8 Cellular PRP            
 5.9 Other Types            
              
6 Global Platelet-rich Plasma Therapy (prp) Market, By Source             
 6.1 Introduction            
 6.2 Autologous            
 6.3 Allogenic            
 6.4 Other Sources            
              
7 Global Platelet-rich Plasma Therapy (prp) Market, By Application             
 7.1 Introduction            
 7.2 Orthopedics            
 7.3 Dermatology            
 7.4 Dental            
 7.5 Sports Medicine            
 7.6 Chronic Wounds            
 7.7 Ophthalmology            
 7.8 Aesthetic Medicine            
 7.9 Cardiac Muscle Injury            
 7.10 Other Applications            
              
8 Global Platelet-rich Plasma Therapy (prp) Market, By End User             
 8.1 Introduction            
 8.2 Hospitals            
 8.3 Clinics            
 8.4 Research and Academic Institutes            
 8.5 Other End Users            
              
9 Global Platelet-rich Plasma Therapy (prp) Market, By Geography             
 9.1 Introduction            
 9.2 North America            
  9.2.1 US           
  9.2.2 Canada           
  9.2.3 Mexico           
 9.3 Europe            
  9.3.1 Germany           
  9.3.2 UK           
  9.3.3 Italy           
  9.3.4 France           
  9.3.5 Spain           
  9.3.6 Rest of Europe           
 9.4 Asia Pacific            
  9.4.1 Japan           
  9.4.2 China           
  9.4.3 India           
  9.4.4 Australia           
  9.4.5 New Zealand           
  9.4.6 South Korea           
  9.4.7 Rest of Asia Pacific           
 9.5 South America            
  9.5.1 Argentina           
  9.5.2 Brazil           
  9.5.3 Chile           
  9.5.4 Rest of South America           
 9.6 Middle East & Africa            
  9.6.1 Saudi Arabia           
  9.6.2 UAE           
  9.6.3 Qatar           
  9.6.4 South Africa           
  9.6.5 Rest of Middle East & Africa           
              
10 Key Developments             
 10.1 Agreements, Partnerships, Collaborations and Joint Ventures            
 10.2 Acquisitions & Mergers            
 10.3 New Product Launch            
 10.4 Expansions            
 10.5 Other Key Strategies            
              
11 Company Profiling             
 11.1 Arthrex, Inc            
 11.2 Zimmer Biomet            
 11.3 EmCyte Corporation            
 11.4 Dr. PRP USA LLC            
 11.5 Juventix Regenerative Medical LLC            
 11.6 Johnson & Johnson Services, Inc.            
 11.7 Terumo Corporation            
 11.8 Stryker            
 11.9 Apex Biologix            
 11.10 Celling Biosciences, Inc            
              
List of Tables              
1 Global Platelet-rich Plasma Therapy (prp) Market Outlook, By Region (2021-2030) ($MN)             
2 Global Platelet-rich Plasma Therapy (prp) Market Outlook, By Type (2021-2030) ($MN)             
3 Global Platelet-rich Plasma Therapy (prp) Market Outlook, By Pure-Platelet-rich Plasma (P-PRP) (2021-2030) ($MN)             
4 Global Platelet-rich Plasma Therapy (prp) Market Outlook, By Leukocyte-rich Platelet-rich Plasma (L-PRP) (2021-2030) ($MN)             
5 Global Platelet-rich Plasma Therapy (prp) Market Outlook, By Pure-Platelet-rich Fibrin (P-PRF) (2021-2030) ($MN)             
6 Global Platelet-rich Plasma Therapy (prp) Market Outlook, By Leukocyte-rich Platelet-rich Fibrin (L-PRF) (2021-2030) ($MN)             
7 Global Platelet-rich Plasma Therapy (prp) Market Outlook, By Activated PRP (2021-2030) ($MN)             
8 Global Platelet-rich Plasma Therapy (prp) Market Outlook, By Autologous Conditioned Plasma (ACP) (2021-2030) ($MN)             
9 Global Platelet-rich Plasma Therapy (prp) Market Outlook, By Cellular PRP (2021-2030) ($MN)             
10 Global Platelet-rich Plasma Therapy (prp) Market Outlook, By Other Types (2021-2030) ($MN)             
11 Global Platelet-rich Plasma Therapy (prp) Market Outlook, By Source (2021-2030) ($MN)             
12 Global Platelet-rich Plasma Therapy (prp) Market Outlook, By Autologous (2021-2030) ($MN)             
13 Global Platelet-rich Plasma Therapy (prp) Market Outlook, By Allogenic (2021-2030) ($MN)             
14 Global Platelet-rich Plasma Therapy (prp) Market Outlook, By Other Sources (2021-2030) ($MN)             
15 Global Platelet-rich Plasma Therapy (prp) Market Outlook, By Application (2021-2030) ($MN)             
16 Global Platelet-rich Plasma Therapy (prp) Market Outlook, By Orthopedics (2021-2030) ($MN)             
17 Global Platelet-rich Plasma Therapy (prp) Market Outlook, By Dermatology (2021-2030) ($MN)             
18 Global Platelet-rich Plasma Therapy (prp) Market Outlook, By Dental (2021-2030) ($MN)             
19 Global Platelet-rich Plasma Therapy (prp) Market Outlook, By Sports Medicine (2021-2030) ($MN)             
20 Global Platelet-rich Plasma Therapy (prp) Market Outlook, By Chronic Wounds (2021-2030) ($MN)             
21 Global Platelet-rich Plasma Therapy (prp) Market Outlook, By Ophthalmology (2021-2030) ($MN)             
22 Global Platelet-rich Plasma Therapy (prp) Market Outlook, By Aesthetic Medicine (2021-2030) ($MN)             
23 Global Platelet-rich Plasma Therapy (prp) Market Outlook, By Cardiac Muscle Injury (2021-2030) ($MN)             
24 Global Platelet-rich Plasma Therapy (prp) Market Outlook, By Other Applications (2021-2030) ($MN)             
25 Global Platelet-rich Plasma Therapy (prp) Market Outlook, By End User (2021-2030) ($MN)             
26 Global Platelet-rich Plasma Therapy (prp) Market Outlook, By Hospitals (2021-2030) ($MN)             
27 Global Platelet-rich Plasma Therapy (prp) Market Outlook, By Clinics (2021-2030) ($MN)             
28 Global Platelet-rich Plasma Therapy (prp) Market Outlook, By Research and Academic Institutes (2021-2030) ($MN)             
29 Global Platelet-rich Plasma Therapy (prp) Market Outlook, By Other End Users (2021-2030) ($MN)             
              
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.              

List of Figures

RESEARCH METHODOLOGY


Research Methodology

We at Stratistics opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.

Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.

Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.

Data Mining

The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.

Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.

Data Analysis

From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:

  • Product Lifecycle Analysis
  • Competitor analysis
  • Risk analysis
  • Porters Analysis
  • PESTEL Analysis
  • SWOT Analysis

The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.


Data Validation

The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.

We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.

The data validation involves the primary research from the industry experts belonging to:

  • Leading Companies
  • Suppliers & Distributors
  • Manufacturers
  • Consumers
  • Industry/Strategic Consultants

Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.


For more details about research methodology, kindly write to us at info@strategymrc.com

Frequently Asked Questions

In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929

Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.

Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.

All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929

We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

We have 3 different licensing options available in electronic format.

  • Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
  • 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
  • Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.

All our reports are typically be emailed to you as an attachment.

To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.

We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.

Request Customization

We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.

WHY CHOOSE US ?

Assured Quality

Assured Quality

Best in class reports with high standard of research integrity

24X7 Research Support

24X7 Research Support

Continuous support to ensure the best customer experience.

Free Customization

Free Customization

Adding more values to your product of interest.

Safe and Secure Access

Safe & Secure Access

Providing a secured environment for all online transactions.

Trusted by 600+ Brands

Trusted by 600+ Brands

Serving the most reputed brands across the world.

Testimonials